| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Alon Ben-Noon is Chief Executive Officer at NRSN. Alon Ben-Noon's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.8M at current prices.
Net of sales, the NRSN filings show accumulation of 250,000 shares.
Alon Ben-Noon has 1 Form 4 filing on record in June 2026, as Chief Executive Officer at NeuroSense Therapeutics (NRSN), 2026.
The 1 reported transaction was 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $200K and no sales.
The only open-market purchase was 250,000 shares of NRSN at an average $0.80 on June 16, 2026, about $200K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | NRSN Neurosense Therapeutics Ltd. | Chief Executive Officer | Buy | 250,000 | $0.80 | $200,000.00 | +5.8% | +887.1% | - |